Azitra AZTR
NYSE AZTR
$0.13 +0.01 (+4.81%)
At close: Aug 21, 2026 · 4:00 PM EDT

Azitra (AZTR) Change in Accured Expenses (2022 - 2026)

Azitra's (AZTR) quarterly Change in Accured Expenses came in at $542064.0 in Q1 2026, up 933.44% YoY from $52452.2 in Q1 2025, and up 191.28% on a QoQ basis from -$593872.0 in Q4 2025.

Azitra (AZTR) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Azitra (AZTR) has 5 years of Change in Accured Expenses data on file, last reported at $542064.0 in Q1 2026.

  • Quarterly Change in Accured Expenses rose 933.44% year-over-year to $542064.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106785.0 (up 41.4% YoY) and the FY2025 annual result came in at -$500318.0, down 256.01% from the prior year.
  • Change in Accured Expenses grew to $542064.0 in Q1 2026, from -$593872.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $542064.0 in Q1 2026 to a low of -$593872.0 in Q4 2025.
  • A 5-year average of $7950.1 and a median of $24845.0 in 2024 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 5430.88% — and 2026, when it surged 933.44%.
  • Tracing AZTR's Change in Accured Expenses over 5 years: stood at $422616.0 in 2022, then slumped by 82.26% to $74978.0 in 2023, then tumbled by 66.86% to $24845.0 in 2024, then slumped by 2490.31% to -$593872.0 in 2025, then soared by 191.28% to $542064.0 in 2026.
  • The last three Change in Accured Expenses figures came in at $542064.0 (Q1 2026), -$593872.0 (Q4 2025), and $53122.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Azitra 2.53 Mn 2.53 Mn - 15,159.00

Historic Data

Download Data
DateValue
Jun 30, 2026 15,159.00
Jun 30, 2026 15,159.00
Mar 31, 2026 542,064.00
Mar 31, 2026 542,064.00
Dec 31, 2025 -593,872.00
Dec 31, 2025 -593,872.00
Sep 30, 2025 53,122.00
Sep 30, 2025 53,122.00
Jun 30, 2025 105,471.00
Jun 30, 2025 105,471.00
Mar 31, 2025 -65,039.00
Mar 31, 2025 -65,039.00
Dec 31, 2024 24,845.00
Dec 31, 2024 24,845.00
Sep 30, 2024 -326,143.00
Sep 30, 2024 -326,143.00
Jun 30, 2024 441,859.00
Jun 30, 2024 441,859.00
Mar 31, 2024 -281,096.00
Mar 31, 2024 -281,096.00